David M Peng
Overview
Explore the profile of David M Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Esteso P, Auerbach S, Bansal N, Harris R, Soslow J, Birnbaum B, et al.
Cardiol Young
. 2025 Feb;
:1-6.
PMID: 40012319
Introduction: Duchenne muscular dystrophy is a devastating neuromuscular disorder characterized by the loss of dystrophin, inevitably leading to cardiomyopathy. Despite publications on prophylaxis and treatment with cardiac medications to mitigate...
2.
Edelson J, Raskin A, Absi M, Adachi I, Aljohani O, Alzubi A, et al.
J Heart Lung Transplant
. 2025 Jan;
PMID: 39827929
Background: The Advanced Cardiac Therapies Improving Outcomes Network (ACTION) began in 2018 as a collaborative learning health system committed to improving outcomes in pediatric heart failure, including children and adults...
3.
Griffiths E, Profsky M, Mokshagundam D, Boucek K, Amdani S, Davies R, et al.
Ann Thorac Surg
. 2025 Jan;
119(3):513-522.
PMID: 39818264
Background: The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs), supported by The Society of Thoracic Surgeons, provides detailed information on pediatric patients supported with ventricular assist devices (VADs). Methods:...
4.
George R, Feldman A, McQueen M, Krise-Confair C, Smyth L, Lorts A, et al.
Pediatr Transplant
. 2024 Oct;
28(7):e14862.
PMID: 39445358
Background: Learning Health Networks (LHN) have evolved within medicine over the past two decades, but their integration into transplantation has been more recent. Objectives And Methods: In this paper, we...
5.
McCormick A, Peng D
J Am Coll Cardiol
. 2024 Oct;
84(22):2183-2184.
PMID: 39365221
No abstract available.
6.
Lorts A, VanderPluym C, Adachi I, Perry T, Alexander P, Almond C, et al.
ASAIO J
. 2024 Sep;
70(11):911-919.
PMID: 39330959
Adverse events (AEs) experienced by children and adults with congenital heart disease (CHD) on ventricular assist devices (VADs) are sometimes unique to these populations. The Advanced Cardiac Therapies Improving Outcomes...
7.
Bonilla-Ramirez C, Lorts A, Spinner J, Wright L, Niebler R, Peng D, et al.
ASAIO J
. 2024 Aug;
71(3):270-275.
PMID: 39150771
We sought to develop and validate a new risk stratification score for mortality for children supported with a ventricular assist device (VAD). This retrospective, multicenter study used data from patients...
8.
Butts R, Toombs L, Kirklin J, Schumacher K, Conway J, West S, et al.
Circulation
. 2024 Jun;
150(5):362-373.
PMID: 38939965
Background: Waitlist mortality (WM) remains elevated in pediatric heart transplantation. Allocation policy is a potential tool to help improve WM. This study aims to identify patients at highest risk for...
9.
West C, Zhao H, Cantor R, Sood V, Lal A, Beaty C, et al.
Pediatr Transplant
. 2024 Jun;
28(5):e14802.
PMID: 38853134
Background: Limited research exists on the influence of social determinants of health (SDOH) on outcomes in pediatric patients with advanced heart failure receiving mechanical circulatory support. Methods: Linkage of the...
10.
Auerbach S, Arshad A, Azeka E, Cantor R, Kirklin J, Koehl D, et al.
J Heart Lung Transplant
. 2024 Mar;
43(7):1142-1152.
PMID: 38460619
Background: Impacts of ischemic time (IT) on pediatric heart transplant outcomes are multifactorial. We aimed to analyze the effect of prolonged IT on graft loss after pediatric heart transplantation. We...